Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Breast Cancer · Metastasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Mount Sinai Beth Israel, New York, New York, United States

  • Mount Sinai - West, New York, New York, United States

  • Dubin breast Center, New York, New York, United States

    Contact: Study coordinator (Atul G Joshi, MS) · gargiatul.joshi@mssm.edu · 212-824-7320
    Contact: Principal Investigator (Amy Tiersten)
Study leads
  • Amy Tiersten, MD

    Principal Investigator

    Icahn School of Medicine at Mount Sinai